Brudno Brudno JN JN Lam Lam N N Vanasse Vanasse D D Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma Nat Med Nat Med 2020 2020 26 26 2 2 270 270 280 280 10.1038/s41591-019-0737-3 10.1038/s41591-019-0737-3 31959992 31959992. Here, CD19 is linked to B-cell non-Hodgkin lymphoma.